Biogenesis
About Biogenesis
Biogenesis is a company focused on transforming clinical trials by applying decentralization, automation, and speed. Its mission is to redefine the clinical trials landscape by removing logistical complexities and administrative burdens that hinder scientific work. The company envisions drug development and clinical trials transcending traditional constraints through its self-sufficient systems and aims to be the backbone of groundbreaking medical breakthroughs, including efforts toward a cancer cure. Biogenesis promotes a Drug Research as a Service (DRaaS) model powered by artificial intelligence and novel operational systems to streamline the entire drug development process, empowering individual researchers to manage end-to-end trial operations and enable scientists to devote their full attention to research and innovation.
Company at a glance
Location
Culture & values
Empowers individual researchers to manage end-to-end trial operations, signaling a culture of autonomy and ownership.
AI and novel operational systems are integral to the way work is performed, reflecting a tech-forward, data-driven culture.
Life at Biogenesis
Frequently asked questions
Companies similar to Biogenesis
EVANIUM is a Regensburg, Germany–based life-science startup that aims to unleash the potential of plant compounds. The company uses its OPTISOLV platform to transform plant extracts into highly water-soluble, stable ingredients, serving customers in Germany and the USA and drawing international interest from Korea and beyond. With a 12-person team, EVANIUM has raised 2.2 million euros in seed funding led by Foodlabs and Phis, with investors including Böhringer Ingelheim and Razorfarm, and has earned an award at Vitafood. This year the company reported 350,000 euros in revenue and produced 2.5 tons of raw material, positioning itself as an innovative player in the plant-based ingredient market.
Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.
Founded by Ayla, a former healthcare investor and EMT, and August, a founding engineer with deep expertise in voice and AI healthcare, this San Francisco-based company is transforming emergency medical services billing and claims. Backed by Eniac and Euclid Ventures at the pre-seed stage, the company is already live with customers and approaching $1M in annual recurring revenue. The lean, two-person founding team is deliberately building a small, elite organization focused on solving critical pain points in the EMS industry. With founders who combine both operational healthcare experience and technical sophistication, the company is positioned to bring much-needed innovation to a traditionally fragmented and inefficient market.